Filing Flows

Filing Flows › Viemed Healthcare (VMD) › Guidance & outlook

Viemed Healthcare (VMD) guidance and outlook

Viemed Healthcare's 10-Q filed Nov 4, 2026 makes 10 forward-looking statements.

Guidance and outlook

Viemed Healthcare: what its forward-looking statements are about (10-Q filed 2026-11-04)Viemed Healthcare: what its forward-looking statements are about (10-Q filed 2026-11-04)Costs4Legal & regulation1People1Other1Buybacks & dividends1Financing1Deals1
10 statements; tone +0.50 (−1 all cautious, +1 all confident); 1 hedged.
Viemed Healthcare: outlook statements against the filing beforeViemed Healthcare: outlook statements against the filing beforeConfident5

Forward-looking statements, 10-Q filed Nov 4, 2026

Viemed Healthcare's latest quarter

Viemed Healthcare, Q3 2026: revenue $80.7M (+12% year over year), operating margin 8.6%, net earnings $4.6M, operating cash flow $11.5M. The chart follows the revenue to costs, profit and cash.

Questions

What does Viemed Healthcare expect?

We will continue to file annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K with the SEC and with the relevant Canadian securities regulatory authorities on the System for Electronic Document Analysis and Retrieval (SEDAR). We expect to grow through expansion of existing service areas as well as in new territories through a cost efficient launch that reduces location expenses. We expect to expand our workforce of licensed clinical practitioners, including RTs, to support our growth and ensure the high service model is maintained in the home.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.